4 Results for "

PI3KC2α

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PI3KC2α" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-112613
CAS No.: 1616413-96-7
Purity:  99.59%
Target:  

PI4K

Research Areas:  

Inflammation/Immunology

UCB9608 is a potent, selective and orally active PI4KIIIβ inhibitor, with an IC50 of 11 nM, selective over PI3KC2 α, β, and γ lipid kinases. UCB9608 improves metabolic stability and exhibits excellent pharmacokinetic profile, acts as a potent immunosuppressive agent .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-156406
CAS No.: 3032439-98-5
Purity:  99.97%
Target:  

PI3K

Research Areas:  

Inflammation/Immunology

PITCOIN4 is a highly selective Class II Alpha PI3K-C2α inhibitor. PITCOIN4 shows nanomolar inhibition of PI3K-C2α and >100-fold selectivity in a general kinase panel .
loading...
    loading...
Cat. No.: HY-156371
CAS No.: 2569296-51-9
Purity:  99.61%
Target:  

PI3K

MIPS-21335 is a PI3KC2α inhibitor with an IC50 of 7 nM. MIPS-21335 also inhibits PI3KC2β, p110α, p110β and p110δ, with IC50 values of 43, 140, 386 and 742 nM, respectively. MIPS-21335 has antithrombotic effect. MIPS-21335 can be used for the researches of cardiovascular disease and metabolic disease, such as thrombosis and hyperlipidemia .
loading...
    loading...
Cat. No.: HY-118903
CAS No.: 711025-68-2
Target:  

PI3K

Research Areas:  

Cancer

PIK-124 is a thiazolidinone-based PI3Kγ-biased PI3K inhibitor, with an IC50 of 3 nM against PI3Kγ. PIK-124 exhibits cross-reactivity with PI3Kα (IC50 = 23 nM), PI3Kδ (IC50 = 340 nM), PI3KC2α (IC50 = 140 nM) and PI3KC2β (IC50 = 370 nM). PIK-124 is applicable to breast cancer-related research .
loading...
    loading...